ImmuneOncia Therapeutics, Inc. (KOSDAQ:424870)
South Korea · Delayed Price · Currency is KRW 8,200.00
-270.00 (-3.19%)
At close: Feb 26, 2026
ImmuneOncia Therapeutics Market Cap
ImmuneOncia Therapeutics has a market cap or net worth of 620.76 billion as of February 27, 2026.
Market Cap
620.76B
Enterprise Value
589.19B
Revenue
715.75M
Ranking
n/a
PE Ratio
n/a
Stock Price
8,200.00
Market Cap Chart
Since May 19, 2025, ImmuneOncia Therapeutics's market cap has increased from 547.53B to 620.76B, an increase of 13.37%. That is a compound annual growth rate of 17.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 620.76B | -35.71% |
| Dec 30, 2025 | 965.63B | 76.36% |
| May 19, 2025 | 547.53B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| G2GBIO | 1.78T |
| Myung In Pharmaceutical LTD. | 966.52B |
| Samyang Biopharm | 722.02B |
| HEM Pharma | 573.02B |
| CellBion | 355.43B |
| DAE HWA Pharmaceutical | 291.48B |
| NOVAREX | 244.82B |
| OPTUS Pharmaceutical | 207.88B |